Navigation Links
PRA International Oncology Experts at ASCO
Date:5/29/2009

RALEIGH, N.C., May 29 /PRNewswire/ -- PRA International, a leading Clinical Research Organization with expertise in Oncology, recently hosted an Oncology audioconference and announces it will exhibit at the 2009 American Society of Clinical Oncology (ASCO) meeting in Orlando, Florida, May 30 through June 1. The audioconference, which drew over 250 attendees, took place on May 19, 2009, and was presented by John Constant, PhD, PRA's VP Scientific Affairs, Statistical Consulting - Oncology/Hematology. The audio conference explored Adaptive/Novel Designs in Oncology - Overview and Issues. For a recording of the audioconference, please contact endpoints@praintl.com.

Dr. Constant and several of PRA's other Oncology experts and PRA leadership will be available for strategic discussions related to oncology trials during ASCO at PRA's booth #3523. For information on PRA events at ASCO, please go to www.prainternational.com and click on News and Events.

As a leader in Oncology and Hematology research, PRA has participated in more than 400 Oncology and Hematology global trials in all phases of development and virtually every indication. PRA conducted pivotal trials and/or key NDA support services for five approved oncology drugs in the past six years. In addition to PRA's scientific experts who provide support during the entire product development lifecycle, nearly 75% of PRA's CRAs and nearly 80% of PRA's Project Managers/Directors have Oncology experience. PRA has worked with and understands the unique development requirements of cancer treatment products.

About PRA International

PRA International is a global Clinical Research Organization providing services through all pha
'/>"/>

SOURCE PRA International
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Gifford Named Zeus Director of International Sales
2. Profiles International Releases New Report on Top 5 Management Failures and Remedies for Success
3. 5th International Scientific Symposium on Tourette Syndrome to Focus on Latest Research and Treatment
4. Family Health International Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research Project Led by David Sokal, M.D.
5. PAREXEL International to Present at Goldman Sachs Annual Global Healthcare Conference and the Jefferies Annual Healthcare Conference
6. Childrens Health Fund Receives $500,000 from the Starr International Foundation to Support South Bronx Homeless Health Care Clinic
7. PRA International Opens Additional Drug Safety Center in Sao Paulo, Brazil
8. International Food Protection Training Institute to Deliver Inaugural Training Course to Food Safety Regulators
9. Academic Leader Joins Medical Management International Board of Directors
10. Curve ball wins international illusion contest
11. International Cooperation to Save Drug-Addicted Kids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
(Date:12/4/2009)Dental tourism is a phenomenon that was started by people that were looking for an alternative to the high price of dental work in the US, Canada, and other countries. In their search for lower priced
(Date:12/4/2009)Move a response to pressure from federal regulators to crack down on abuse of opioid medications , , FRIDAY, Dec. 4 (HealthDay News) -- The makers of 24 different prescription painkillers on F
(Date:12/4/2009)Research and surveillance urged for at-risk patient groups , , FRIDAY, Dec. 4 (HealthDay News) -- Some childhood cancers, particularly Ewing sarcomas and central nervous system tumors, carry t
Breaking Medicine News(10 mins):Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3Health News:Makers of Powerful Painkillers Present Safety Plans 2
...edical,Foundation has been awarded a three-year te...rvices as the result of a recent survey by the Ame...detailed, concerted effort our team made to ensure...tified radiologist at Sutter Regional Medical Foun...
... Researchers from EPFL and Caltech have made an i...earn to predict risk. The research, appearing in ... will shed light on why certain kinds of risk, not...eous evaluation of risk. , Planning entails maki...
...rs and sisters can be tough work, as any youngest ...ologist at the University of North Carolina at Cha...ou should reserve any underdog sympathies for the ...om, which holds that baby birds that are laid befo...
...mission tomography (PET) and computed tomography (...ve method to evaluate response to radiation therap...up treatments, a study by researchers at the Unive...ailable online. , The clinical study is the first...
...tiatives are featured, DETROIT, March 12 Physici... inside look at how groundbreaking partnerships,am...ld of Michigan are,saving lives, improving patient...ted,by hospitals, physicians and the Blues to trul...
... National Chronic Disease ...rim results show,that participants in the Diabetes... clinical and patient satisfaction indicators in t...lling diabetes, the chronic,disease that affects 2...
Other Medicine News:Health News:Sutter Regional Medical Foundation Receives ACR Accreditation 2Health News:To bet or not to bet: How the brain learns to estimate risk 2Health News:Early bird doesn't always get worm, UNC researcher finds 2Health News:USC researchers find benefit for lymphoma patients in combined PET-CT scanning 2Health News:Partnerships Report Highlights How Blue Cross Blue Shield of Michigan, Physicians and Hospitals Are Working to Save Lives, Improve Care, Reduce Costs 2Health News:Partnerships Report Highlights How Blue Cross Blue Shield of Michigan, Physicians and Hospitals Are Working to Save Lives, Improve Care, Reduce Costs 3Health News:Partnerships Report Highlights How Blue Cross Blue Shield of Michigan, Physicians and Hospitals Are Working to Save Lives, Improve Care, Reduce Costs 4Health News:Diabetes Ten City Challenge Collaborative Model Shows Improved Patient Health Across Key Clinical Indicators 2Health News:Diabetes Ten City Challenge Collaborative Model Shows Improved Patient Health Across Key Clinical Indicators 3Health News:Diabetes Ten City Challenge Collaborative Model Shows Improved Patient Health Across Key Clinical Indicators 4
(Date:12/3/2009)SAN DIEGO, Dec. 3 BioMed Realty Trust, Inc. (NYSE: BMR ) announced today that it has entered into a new lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) for approximately 131,000 square
(Date:12/3/2009)HOERSHOLM, Denmark and SAN DIEGO, California, December 3 , - SPC3649 Successfully Inhibits miR-122, a microRNA Important for,Hepatitis C Viral Replication, Thereby Significantly Reducing Hepatiti
(Date:12/3/2009)COSTA MESA, Calif., Dec. 3 TROY Group, Inc., a Worldwide Leader in Secure on-Demand Printing Solutions, announces the addition of the TROY 3015 SecureRx(TM) Printer to its line of secure prescripti
Breaking Medicine Technology:BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5New TROY SecureRx Prescription Printer Marks 50th Hospital Installation Milestone 2Basic Facts and Statistics About Lupus 51277 1Basic Facts and Statistics About Lupus 51277 2AUL President to Senate Judiciary Committee 3A Ask Top 10 Questions to Judge Sotomayor 51274 1AUL President to Senate Judiciary Committee 3A Ask Top 10 Questions to Judge Sotomayor 51274 2REMERON 28R 29 Now Approved in Japan for the Treatment of Depression in Adult Patients 12964 1REMERON 28R 29 Now Approved in Japan for the Treatment of Depression in Adult Patients 12964 2REMERON 28R 29 Now Approved in Japan for the Treatment of Depression in Adult Patients 12964 3REMERON 28R 29 Now Approved in Japan for the Treatment of Depression in Adult Patients 12964 4REMERON 28R 29 Now Approved in Japan for the Treatment of Depression in Adult Patients 12964 5
...EULAR, BARCELONA, Spain, June 15, 2007 /PRNewswire...n League Against Rheumatism (EULAR),Annual Europea...th,ankylosing spondylitis (AS) who received REMICA...ificant improvement in spinal,mobility. In additio...ctions in spinal inflammation through two years as...
...dic: ACTI) presented,pre-clinical results for the ...gue Against Rheumatism, <a target="_blank" href=,"..., June,13-16*. , "The new pre-clinical data presen...fect on disease development in an,experimental mod...Andréasson, President & CEO Active Biot...
Other Medicine Technology:Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 2Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 3Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 4Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 5Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 6Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 7Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 8Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 9Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 10Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 11Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 12New Positive Pre-clinical Data for Active Biotech's RA Project I-3D 2
Broncho-Cath® Endobronchial Tube with CPAP System
...made of silicone rubber with a wire reinforced end... of silicone rubber, Silbronco is soft and less tr...the tube will not soften like PVC tubes, which mak...lbronco is also especially useful when a tumor lif...
Portex Pedia-Trake® Pediatric Emergency Cricothyrotomy Kit
Melker Emergency Cricothyrotomy Catheter Sets
Medicine Products: